Andrew J. Harvey - Concepedia

Author

Andrew J. Harvey

Walter and Eliza Hall Institute of Medical Research ORCID

Also Known As

A Harvey, A. Harvey, A. J. Harvey, Andrew Harvey, Andrew J Harvey, Andrew J. Harvey, Harvey, Andrew J.

Publications

370

Citations

H-Index

Concepts

All Affiliations

Walter and Eliza Hall Institute of Medical Research Bionomics (Australia)The University of Melbourne University of Canterbury

About

Andrew J. Harvey is an author at Walter and Eliza Hall Institute of Medical Research specializing in biochemistry, medicine, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	5	5	157
2	Medicine	4	4	93
3	Natural Sciences	3	3	64
4	Health Sciences	1	1	73
5	Public Health	1	1	35

Andrew J. Harvey

Publications

358

Citations

H-Index

Page 1

	Year	Citations
Azobenzene-Containing, Peptidyl α-Ketoesters as Photobiological Switches of α-Chymotrypsin Andrew J. Harvey, Andrew D. Abell Tetrahedron BiochemistryPhotochemistryPhotosystemsMechanistic PhotochemistryPhotobiological Switches	2000	73
Khellinone Derivatives as Blockers of the Voltage-Gated Potassium Channel Kv1.3: Synthesis and Immunosuppressive Activity Jonathan B. Baell, Robert W. Gable, Andrew J. Harvey, Journal of Medicinal Chemistry	2004	54
Congenital fibrinogen disorders: a retrospective clinical and genetic analysis of the Prospective Rare Bleeding Disorders Database Samin Mohsenian, Roberta Palla, Marzia Menegatti, Blood Advances GynecologyPathologyClinical GeneticsGenetic AnalysisThrombosis	2024	35
A New Class of Blockers of the Voltage-Gated Potassium Channel Kv1.3 via Modification of the 4- or 7-Position of Khellinone Andrew J. Harvey, Jonathan B. Baell, Nathan Toovey, Journal of Medicinal Chemistry	2006	29
α-Ketoester-based photobiological switches: synthesis, peptide chain extension and assay against α-chymotrypsin Andrew J. Harvey, Andrew D Abell Bioorganic & Medicinal Chemistry Letters BiochemistryPhotochemistryNatural SciencesPhotobiologyPhototoxicity	2001	26
Synthesis and biological evaluation of chalcones as inhibitors of the voltage-gated potassium channel Kv1.3 Julia Cianci, Jonathan B. Baell, Bernard L. Flynn, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryHyperpolarization (Biology)MedicineNatural Sciences	2008	25
Design and synthesis of type-III mimetics of ShK toxin Jonathan B. Baell, Andrew J. Harvey, Raymond S. Norton Journal of Computer-Aided Molecular Design Combinatorial ChemistryShk Toxin	2002	24
Discovery of BNC375, a Potent, Selective, and Orally Available Type I Positive Allosteric Modulator of α7 nAChRs Andrew J. Harvey, Thomas D. Avery, Laurent Schaeffer, ACS Medicinal Chemistry Letters	2019	22
A three-residue, continuous binding epitope peptidomimetic of ShK toxin as a Kv1.3 inhibitor Andrew J. Harvey, Robert W. Gable, Jonathan B. Baell Bioorganic & Medicinal Chemistry Letters Protein FunctionToxinologyBiochemistryMedicineKv1.3 Inhibitor	2005	20
Pharmacological Characterization of the Novel and Selective α7 Nicotinic Acetylcholine Receptor–Positive Allosteric Modulator BNC375 Xiaohai Wang, Christopher J. A. Daley, Vanita Gakhar, Journal of Pharmacology and Experimental Therapeutics	2020	16

Page 1